Mixture Cure Survival Analysis Model for Cardiovascular Disease in Sulaimani, Iraq


Cardiovascular disease(CVDs) is one of the leading causes of death world- wide. Iraq ranks 20th in the age adjusted Death Rate due to CDVs. In recent years, the treatment of many diseases, especially heart disease, has significantly improved, so the number of patients who do not experience the desired outcome, including death, has increased. In statistical analysis of this type of diseases, cure models are used instead of the usual survival models. In this paper, a sample include 919 patients referred to Sulaimani Hospital with heart disease (including 365 female and 554 male) were followed up for a maximum of 650 days, during the years 2020 to 2022. Of these, 162 people, or 17.6%, have died. Since the Maller-Zhou test was significant (P < 0.01) and considering the cured fraction in this population, the mixture cure model with some statistical distributions was fitted to the data. Based on the re- sults and comparing AIC and BIC, it was observed that the healed model combined with Weibull distribution for survival time and Poisson distribu- tion for the number of deaths with the AIC=1972.54 , BIC=2092.985 was the best model.

DOI Code: 10.1285/i20705948v15n1p95

Keywords: mixture cure survival;cardiovascular disease;Weibull distribution; Iraq


Berkson, J. and Gage, R. P. (1952). Survival curve for cancer patients following treat- ment. Journal of the American Statistical Association, 47:501–515.

Boag, J. W. (1949). Maximum likelihood estimates of the proportion of patients cured by cancer therapy. Journal of the Royal Statistical Society, 11:15–53.

Chen, J. G. I. M.-H. and Sinha, D. (2001). Bayesian Survival Analysis. New York: Springer.

Collett, D. (2015). Modelling survival data in medical research. CRC press.

Cox, D. R. (1972). Regression models and life-tables. Journal of the royal statistical

society series b-methodological, 34:187–220.

Farewell, V. (1982). The use of mixture models for the analysis of survival data with long-term survivors. Biometrics, pages 1041–1046.

Hastie, T., Tibshirani, R., and Friedman, J. (2001). The Elements of Statistical Learning.

Springer Series in Statistics. Springer New York Inc., New York, NY, USA.

John P. Klein, Hans C. van Houwelingen, J. G. I. and Scheike, T. H. (2014). Handbook

of Survival Analysis. Boca Raton: CRC Press.

Klein, J. P. and Moeschberger, M. L. (2005). Survival analysis: techniques for censored

and truncated data. Springer Science & Business Media.

Kleinbaum, D. G. and Klein, M. (2012). Survival Analysis: A Self-learning Text. Springer

Science & Business Media.

Lambert, P. C. (2007). Modeling of the cure fraction in survival studies. Stata Journal, 7(3):351–375.

Liang, H. and Zou, G. (2008). Improved aic selection strategy for survival analysis. Comput Stat Data Anal, 52(5):2538–2548.

Maller, R. A. and Zhou, S. (1992). Estimating the proportion of immunes in a censored sample. Biometrika, 79(4):731–739.

Maller, R. A. and Zhou, X. (1996). Survival analysis with long-term survivors. Wiley New York.

Mohammad, K. A., Hirose, Y., Surya, B., and Yao, Y. (2020). Ecient estimation for the cox proportional hazards cure model.

Murphy, K. P. (2013). Machine learning : a probabilistic perspective. MIT Press, Cam- bridge, Mass. [u.a.].

Sy, J. P. and Taylor, J. M. (2000). Estimation in a cox proportional hazards cure model. Biometrics, 56(1):227–236.

Tsodikov A, Joseph G. Ibrahim, Y. A. (2003). Estimating cure rates from survival data: an alternative to two-component mixture models. J Am Statist Ass., 98(464):1063– 1078.

Volinsky CT, R. A. (2000). Bayesian information criterion for censored survival models. Biometrics, 56(1)::256–262.

Wu, Y., Lin, Y., Lu, S.-E., Li, C.-S., and Shih, W. J. (2014). Extension of a cox propor- tional hazards cure model when cure information is partially known. Biostatistics, 15 3:540–54.

Full Text: pdf

Creative Commons License
This work is licensed under a Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia License.